Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin | Zendy

AI Assistant Blog Pricing

Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.